ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00324194
Recruitment Status : Completed
First Posted : May 10, 2006
Last Update Posted : January 8, 2015
Sponsor:
Information provided by:
Mirati Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2008
  Actual Study Completion Date : August 2008